1999
Infertility Treatment and Informed Consent
HOUMARD B, SEIFER D. Infertility Treatment and Informed Consent. Obstetrics And Gynecology 1999, 93: 252-257. DOI: 10.1097/00006250-199902000-00018.Peer-Reviewed Original ResearchOvulation inductionCurrent practice patternsInfertility treatmentOvarian cancerReproductive endocrinologistsInformed consentIntrauterine inseminationPractice patternsMost physiciansBoard-certified reproductive endocrinologistsReproductive technologiesPatients of risksOvarian cancer riskLength of treatmentLogistic regression analysisMajority of physiciansAssisted Reproductive TechnologyInvasive therapyCancer riskVerbal consentPossible associationCancerEndocrinologistsPhysiciansCommon changesInfertility treatment and informed consent: current practices of reproductive endocrinologists.
Houmard BS, Seifer DB. Infertility treatment and informed consent: current practices of reproductive endocrinologists. Obstetrics And Gynecology 1999, 93: 252-7. PMID: 9932565, DOI: 10.1016/s0029-7844(98)00389-5.Peer-Reviewed Original ResearchConceptsOvulation inductionCurrent practice patternsInfertility treatmentOvarian cancerReproductive endocrinologistsInformed consentIntrauterine inseminationPractice patternsMost physiciansBoard-certified reproductive endocrinologistsReproductive technologiesPatients of risksOvarian cancer riskLength of treatmentLogistic regression analysisMajority of physiciansAssisted Reproductive TechnologyInvasive therapyCancer riskVerbal consentPossible associationEndocrinologistsCancerPhysiciansCommon changes
1997
Multiple Immunoreactive Inhibin Proteins in Serum from Postmenopausal Women with Epithelial Ovarian Cancer
Lambert-Messerlian GM, Steinhoff M, Zheng W, Canick JA, Gajewski WH, Seifer DB, Schneyer AL. Multiple Immunoreactive Inhibin Proteins in Serum from Postmenopausal Women with Epithelial Ovarian Cancer. Gynecologic Oncology 1997, 65: 512-516. PMID: 9190984, DOI: 10.1006/gyno.1997.4719.Peer-Reviewed Original ResearchConceptsEpithelial ovarian cancerPostmenopausal womenCA 125Serum markersOvarian cancerAlpha-inhibin precursorsDimeric inhibin APro-alphaC levelsSerum of womenPreoperative serum levelsGood serum markerInhibin proteinPotential serum markerAlphaC inhibinTotal inhibinInhibin BInhibin secretionSerum levelsInhibin AInhibinNonspecific assaysEOC casesWomenCancerSerum
1988
Cytoreduction of ovarian cancer with the Cavitron ultrasonic surgical aspirator.
Adelson MD, Baggish MS, Seifer DB, Cassell SL, Thompson MA. Cytoreduction of ovarian cancer with the Cavitron ultrasonic surgical aspirator. Obstetrics And Gynecology 1988, 72: 140-3. PMID: 3380505.Peer-Reviewed Original ResearchConceptsCavitron Ultrasonic Surgical AspiratorUltrasonic surgical aspiratorSurgical techniqueSurgical aspiratorStage IIIC diseaseIntra-abdominal malignanciesStandard surgical techniqueIIIC diseaseVisceral resectionsSmall bowelMean ageSurgical timeOvarian cancerTumor removalCytoreductionResectionPatientsDiseaseAspiratorBowelAdnexaMalignancyOmentumInjuryUterus
1986
Critical reassessment of “second-look” exploratory laparotomy in epithelial ovarian cancer. II. Prognostic factors and treatment outcome in patients with persistent cancer
Miller D, Ballon S, Soriero O, Teng N, Seifer D. Critical reassessment of “second-look” exploratory laparotomy in epithelial ovarian cancer. II. Prognostic factors and treatment outcome in patients with persistent cancer. Gynecologic Oncology 1986, 23: 253-254. DOI: 10.1016/0090-8258(86)90256-8.Peer-Reviewed Original Research